StageBio is delighted to announce that David Bruning is joining our team as our new CEO and President.
StageBio is delighted to announce that David Bruning is joining our team as our new CEO and President.
Meet our featured StageBio pathologist, Dr. Shannon Kirejczyk (“Kir-8-sick”), DVM, MPH, PhD, DACVP, Pathologist/Principal Investigator
StageBio announces that Lori Wright, RQAP-GLP, Senior Director, Quality and Regulatory of StageBio, has been designated as the Society of Quality Assurance’s Vice President for the 2024 term.
Meet December’s featured StageBio pathologist, Dr. Tracey Papenfuss Dr. Tracey Papenfuss BS, DVM, MS, PhD (Immunology), DACVP, FIATP, Senior Pathologist/Principal Investigator, Immune Service Lead
Meet our featured StageBio pathologist, Dr. Sureshkumar Muthupalani, BVSc, MVSc, PhD, DACVP
A StageBio team member is a contributing author on a book published to help researchers determine whether pathologic changes observed in laboratory non-human primates (NHP) are spontaneous or the result of other factors.
Meet our featured StageBio pathologist, Dr. Quinci Plumlee, DVM, MS, DACVP, Senior Pathologist
Meet our featured StageBio pathologist, Dr Stephanie Shrader: DVM, Phd, DACVP, Director, General Toxicologic Pathology!
StageBio, a leading provider of histology, pathology, image analysis, specimen archiving and biorepository services, is pleased to announce a strategic partnership with Pathcore, an innovative digital and computational pathology solutions provider. This collaboration marks a significant milestone in the advancement of pathology solutions, offering enhanced digital workflows, and improved efficiency for clients worldwide.
StageBio announces the addition of DuraTemp ULT Backup Solution to its biorepository and archiving facility repertoire.
Date: May 3-7
Location: Denver, CO
Booth #9065
Date: May 3-5
Location: Basel, Switzerland
Date: May 11-15
Location: Boston, MA